The aspect of the change in the expression of PD-L1 of tumor cells after the application of the DC vaccine, on the one hand, indicates the activation of the tumor “escape” processes, but, on the other hand, makes it possible to include an effective additional immunotherapy using ICIs in the treatment process (32). This evidence concerns the gene CD274 and neoplasm.